Multiple sclerosis is a chronic, demyelinating disease of the CNS. Cognitive impairment is a
sometimes neglected, yet common, sign and symptom with a profound effect on instrumental …

Purpose: To promote understanding of cognitive impairment in multiple sclerosis (MS),
recommend optimal screening, monitoring, and treatment strategies, and address barriers to …

Multiple sclerosis (MS) is a chronic disease that is characterized by demyelination and
axonal damage in the central nervous system. Cognitive deficits are recognized as one of …

An international expert consensus committee recently recommended a brief battery of tests
for cognitive evaluation in multiple sclerosis. The Brief International Cognitive Assessment …

Cognitive impairment is common in multiple sclerosis (MS), especially when assessed by
neuropsychological tests that emphasize mental processing speed, episodic memory, and …

Cognitive impairment is a common and debilitating feature of multiple sclerosis (MS) that
has only recent gained considerable attention. Clinical neuropsychological studies have …

The Canadian Multiple Sclerosis Working Group (CMSWG) developed practical
recommendations in 2004 to assist clinicians in optimizing the use of disease-modifying …

Cognitive dysfunction is common in multiple sclerosis (MS), yet the magnitude of change on
objective neuropsychological (NP) tests that is clinically meaningful is unclear. We …

Abstract Cognitive dysfunction involves 40–65% of multiple sclerosis patients and can have
a great functional impact. It can be detected in all the disease phenotypes since the early …

Objective: To assess longitudinally cognitive functioning in relapsing—remitting multiple
sclerosis (RRMS) patients and its relationship with clinical and MRI variables. Methods …